Acuta Capital Partners’s ViewRay, Inc. VRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-842,500
Closed -$7.42M 35
2019
Q2
$7.42M Buy
842,500
+27,500
+3% +$223K 2.64% 15
2019
Q1
$6.02M Buy
815,000
+503,500
+162% +$3.88M 2.86% 12
2018
Q4
$1.89M Hold
311,500
1.44% 18
2018
Q3
$2.92M Sell
311,500
-1,183,500
-79% -$11.6M 1.04% 21
2018
Q2
$10.3M Sell
1,495,000
-357,878
-19% -$2.6M 1.84% 12
2018
Q1
$11.9M Sell
1,852,878
-62,776
-3% -$523K 1.95% 15
2017
Q4
$17.7M Buy
1,915,654
+583,671
+44% +$4.67M 3.35% 10
2017
Q3
$7.67M Buy
1,331,983
+645,596
+94% +$3.64M 1.37% 18
2017
Q2
$4.44M Buy
686,387
+85,314
+14% +$571K 1.24% 19
2017
Q1
$4.64M Buy
+601,073
New +$3.28M 1.1% 27

Other funds holding VRAY

Acuta Capital Partners's VRAY Position: Q3 2019 in Review

Acuta Capital Partners sold out of ViewRay, Inc. (VRAY) in Q3 2019, closing a stake of 842,500 shares — an estimated $7.42M sold.

Acuta Capital Partners first reported a position in VRAY in Q1 2017 and held it in 10 quarters. The position peaked at $17.7M in Q4 2017. 145 funds tracked by Wall St. Rank hold VRAY as of Q3 2019.

  • Acuta Capital Partners reported no remaining ViewRay, Inc. position as of Q3 2019 after selling out during the quarter.
  • Acuta Capital Partners sold 842,500 ViewRay, Inc. shares in Q3 2019, an estimated $7.42M.
  • Acuta Capital Partners first reported a position in ViewRay, Inc. in Q1 2017 and held it in 10 quarters.
  • Acuta Capital Partners's ViewRay, Inc. position peaked at $17.7M in Q4 2017.
  • 145 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q3 2019.

Based on Acuta Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.